The high expression of CCAT1 and CCAT2 was significantly associated with recurrence-free survival and overall survival in colon cancer, gastric cancer, hepatocellular carcinoma, breast cancer, and ovarian cancers [70,71,72]. Here, CCAT2 is linked to ovarian cancer.